-
-
Administers Grant
-
A Multicenter, Open-Label Trial of Intravenous Golimumab, a Human Anti-TNF¿ Antibody, in Pediatric Subjects With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
-
A Phase 2/3 Open-Label, Single-Arm Trial to Evaluate the Safety and Activity of Eculizumab in Pediatric Patients with Relapsing Neuromyelitis Optica Spectrum Disorder
-
A Randomized, Open Label, Multi-Center Phas 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular JIA (Limit-JIA)
-
A randomized, double-blind, placebo-controlled, multicenter, phase 3 efficacy and safety study of 2 dose levels of subcutaneious anakinra in patients with Still's disease
-
ACR/Amgen Rheumatology Fellowship Training Award
-
ACR/Amgen Rheumatology Fellowship Training Award
-
ACR/Amgen Rheumatology Fellowship Training Award
-
ACR/Amgen Rheumatology Fellowship Training Award
-
Adverse Childhood Experiences in Juvenile Idiopathic Arthritis
-
An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered with Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, with Systemic Juvenile Idiopathic Arthritis (sJIA), Followed by an Extensi
-
An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered with Subcutaneous (SC) Injection, in Children and Adolescents, Aged 2 to 17 Years, with Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) Followed b
-
Arthritis Foundation Fellowship Training Grant 2019
-
CARRA
-
CARRA Early Investigator Chair Support
-
CARRA Early Investigator Vice Chair Support
-
CARRA Registry Assistant Scientific Director
-
CARRA Registry Continuation
-
Electronic Diary Assessment of Pain in Juvenile Arthritis
-
Enhancing Clinical Meaningfulness and Usefulness of PROMIS Pediatric Measures Via Validation in Children and Adolescents with Rheumatic Disease, Cancer of Inflammatory Bowel Disease
-
Identifying Pharmacogenomic Predictors of Methotrexate Response and Metabolite Biotransformation in JIA
-
Implementation of Electronic Health Record Optimization Tools to Capture and Extract CARRA Data
-
Improving Pediatric Lupus Care and Outcomes through the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Lupus Registry
-
Improving Pediatric Lupus Care and Outcomes through the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Lupus Registry
-
Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients with Polyarticular-Course adn Systemic Juvenile Idiopathic Arthritis
-
Mental Health Screening in Juvenile Myositis: Pilot and Feasibility Study
-
Metabolomic Analysis of Paired Serum and Skeletal Muscle in Juvenile Inflammatory Myositis Compared to Controls
-
New CARRA Registry
-
Optimizing Hydroxychloroquine to Reduce Disease Activity in Pediatric Lupus
-
PRECISE Study (Precision Biologics in Rheumatology)
-
PULSE: Pediatric Update on Lupus in South Africa: Epidemiology & Management
-
Pediatric Rheumatology Research Annual Scientific Meeting
-
Pediatrics Juvenile Myositis program support
-
Pilot Study for the Implementation of the CARRA Uveitis Consensus Treatment Plans (CTP)
-
Precision Decision in the Treatment of Juvenile Dermatomyositis
-
Precision Decision in the Treatment of the Juvenile idiopathic Inflammatory Myopathies
-
Psychological Stress and Cardiovascular Health in Juvenile Lupus and Dermatomyositis
-
RRF Medical and Graduate Student Preceptorship
-
Regulation Of The T Cell Specific Gene Cd7
-
Regulation Of The T-Cell Specific Gene Cd7
-
Stress, Mood & Disease Activity In Juvenile Rheumatoid Art
-
Tfh cells in Human Myositis
-
Urinary HER2 as a biomarker for lupus nephritis
-
Vamorolone in Juvenile Autoimmune Myositis
-
WA28117: Tocilizumab in Polyarticular-Course JIA
-
WA28118: Tocilizumab in Systemic JIA
-
WebSMART Trial-Year 4